INTERNATIONAL BUSINESS MACHINES CORP (IBM) vs JOHNSON & JOHNSON(JNJ)
Side-by-side comparison from SEC filings: latest annual financials, insider activity and institutional ownership.
| Metric | IBM | JNJ |
|---|---|---|
| Sector | Information Technology | Health Care |
| Latest fiscal year | FY2025 | FY2025 |
| Revenue | $67.53B | $94.19B |
| Revenue growth (YoY) | ▲ 7.6% | ▲ 6.0% |
| Net income | $10.59B | $26.80B |
| Gross margin | 58.2% | 67.9% |
| Diluted EPS | $11.17 | $11.03 |
| Insider net (6 mo) | −22.1K sh · 1 sells · 0 buys | −40.8K sh · 6 sells · 0 buys |
| Institutional owners | 44 | 47 |
| Institutional value held | $124.42B | $294.77B |
| Next earnings (est.) | Around Oct 21, 2026 | Around Oct 13, 2026 |
Figures from each company's SEC filings (latest reported fiscal year; fiscal calendars may differ). Next-earnings dates are estimates from historical filing patterns.
About INTERNATIONAL BUSINESS MACHINES CORP (IBM)
International Business Machines Corporation (IBM), originally incorporated in New York in 1911 as the Computing-Tabulating-Recording Co.
About JOHNSON & JOHNSON (JNJ)
Johnson & Johnson, incorporated in New Jersey in 1887, is a global healthcare holding company with approximately 138,200 full-time-equivalent employees engaged in the research, development, manufacture, and sale of a broad range of healthcare products.
Source: SEC EDGAR.